Gilead Sciences Inc (GILD)
66.04
+1.44
(+2.23%)
USD |
NASDAQ |
May 10, 12:52
Gilead Sciences Total Assets (Quarterly): 56.29B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 56.29B |
December 31, 2023 | 62.12B |
September 30, 2023 | 62.37B |
June 30, 2023 | 62.34B |
March 31, 2023 | 61.88B |
December 31, 2022 | 63.17B |
September 30, 2022 | 62.56B |
June 30, 2022 | 62.87B |
March 31, 2022 | 63.08B |
December 31, 2021 | 67.95B |
September 30, 2021 | 67.10B |
June 30, 2021 | 67.98B |
March 31, 2021 | 67.49B |
December 31, 2020 | 68.41B |
September 30, 2020 | 60.88B |
June 30, 2020 | 55.93B |
March 31, 2020 | 59.74B |
December 31, 2019 | 61.63B |
September 30, 2019 | 59.15B |
June 30, 2019 | 63.21B |
March 31, 2019 | 62.84B |
December 31, 2018 | 63.68B |
September 30, 2018 | 64.30B |
June 30, 2018 | 65.36B |
March 31, 2018 | 65.38B |
Date | Value |
---|---|
December 31, 2017 | 70.28B |
September 30, 2017 | 64.66B |
June 30, 2017 | 60.26B |
March 31, 2017 | 57.70B |
December 31, 2016 | 56.98B |
September 30, 2016 | 56.61B |
June 30, 2016 | 49.98B |
March 31, 2016 | 47.76B |
December 31, 2015 | 51.72B |
September 30, 2015 | 50.64B |
June 30, 2015 | 39.17B |
March 31, 2015 | 38.32B |
December 31, 2014 | 34.66B |
September 30, 2014 | 28.84B |
June 30, 2014 | 31.21B |
March 31, 2014 | 28.08B |
December 31, 2013 | 22.58B |
September 30, 2013 | 22.47B |
June 30, 2013 | 22.62B |
March 31, 2013 | 22.21B |
December 31, 2012 | 21.24B |
September 30, 2012 | 20.96B |
June 30, 2012 | 20.50B |
March 31, 2012 | 19.95B |
December 31, 2011 | 17.30B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
55.93B
Minimum
Jun 2020
68.41B
Maximum
Dec 2020
62.81B
Average
62.46B
Median
Total Assets (Quarterly) Benchmarks
Amgen Inc | 92.98B |
CymaBay Therapeutics Inc (DELISTED) | 434.69M |
Bristol-Myers Squibb Co | 99.03B |
Eli Lilly and Co | 63.94B |
Xilio Therapeutics Inc | 60.93M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 38.84B |
Shareholders Equity (Quarterly) | 17.54B |
Debt to Equity Ratio | 1.436 |
Current Ratio | 1.079 |
Net Debt Paydown Yield | 0.01% |